Glucagon-like peptide-1 receptor agonists as a Therapeutic Option for Antipsychotic-Induced Obesity: A Review of Current Evidence

Glucagon-like peptide-1 receptor agonists as a Therapeutic Option for Antipsychotic-Induced Obesity: A Review of Current Evidence

Introduction Obesity affects over 650 million adults worldwide and is a major risk factor for cardiovascular diseases and type 2 diabetes. Among those affected are patients treated with antipsychotics, such as clozapine and olanzapine, which often lead to significant weight gain, increasing the ris...

Full description

Saved in:
Bibliographic Details
Main Authors: Natalia Gniaź, Aleksandra Górska, Wiktor Grela, Jagoda Niewiadomska, Daria Furtak, Dawid Tulej, Paulina Głogowska, Alicja Dziedzic, Dominika Marciniuk, Natalia Marko
Format: Article
Language:English
Published: Kazimierz Wielki University 2024-12-01
Series:Journal of Education, Health and Sport
Subjects:
obesity
antipsychotic-induced weight gain
clozapine
olanzapine
adverse effect
GLP-1 receptors agonist
Online Access:https://apcz.umk.pl/JEHS/article/view/56672
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items